Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cell Proliferation|May 22, 2024
ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing mannerQi Liu, Chen-Song Huang, Siyun Chen, et al.Cancer Science|August 7, 2019
EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β-catenin at Ser552Xiao-Xu Zhu, Jian-Hui Li, Jian-Peng Cai, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2020
Targeting Super-Enhancers via Nanoparticle-Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal AdenocarcinomaChen-Song Huang, Xinru You, Chunlei Dai, et al.Nanoscale|July 31, 2020
Histone methyltransferase G9a inhibitor-loaded redox-responsive nanoparticles for pancreatic ductal adenocarcinoma therapyJie-Qin Wang, Li-Ying Wang, Shi-Jin Li, et al.Journal of Experimental & Clinical Cancer Research : CR|November 29, 2019
MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathwayJian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 17, 2022
Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancerYin-Hao Shi, Qiong-Cong Xu, Ying-Qin Zhu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 3, 2024
Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal AdenocarcinomaYing-Qin Zhu, Yue Huang, Yin-Hao Shi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 24, 2026
AFP specific T cell receptors with fine-tune affinity induce durable tumor remission in mice and acquire pan-HLA-A*02 recognitionChen-Song Huang, Jiajia Du, Jun Li, et al.Pageof 4